Prevymis (letermovir) - Merck (MSD)
Utilization of Crushed Letermovir in Allogeneic Hematopoietic Cell Transplant and Cellular Therapies (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 1992; Pres time: Oct 23, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available 
Infectious Disease
https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=838587&mode=posterInfo
 
Eric Gaskill, PharmD, BCOP; Yanina Pasikhova, PharmD
 
Sep 6, 2026
 
Prev Next